Comparable stake leader
Fredric N. Eshelman
SEC ownership of Aravive, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001513818.
Disclosed value leader
Fredric N. Eshelman
Comparable rows
0/14
Latest evidence
10 Apr 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Fredric N. Eshelman
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
10 Apr 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001513818
- Issuer location
- Houston, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Aravive, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Fredric N. Eshelman
Disclosed value leader
Fredric N. Eshelman
Comparable rows
0/14
Latest evidence
10 Apr 2023
3/4/5
Highest disclosed value: $23,473,906
14 rows are not safely comparable across share classes.
Showing 1-8 of 14 holder rows.
Quick read
Fredric N. Eshelman has the largest disclosed position value at $23.47M.
0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Fredric N. Eshelman's linked filing trail.
Disclosed position value
Top 4
Fredric N. Eshelman
$23.47M
Eric Zhang
$2.58M
Amato Giaccia
$1.12M
Peter Tai-Ching Ho
$101.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Fredric N. Eshelman |
3/4/5
Executive Chairman, Director, 10%+ Owner
|
—
mixed-class rows
|
$23,473,906
41,824,009 shares
mixed-class rows
|
— | 24 Oct 2022 |
| Eric Zhang |
3/4/5
Director
|
—
mixed-class rows
|
$2,581,796
3,893,680 shares
mixed-class rows
|
— | 24 Oct 2022 |
| Amato Giaccia |
3/4/5
Director
|
—
mixed-class rows
|
$1,116,435
1,485,416 shares
mixed-class rows
|
— | 24 Oct 2022 |
| Peter Tai-Ching Ho |
3/4/5
Director
|
—
mixed-class rows
|
$101,838
219,412 shares
mixed-class rows
|
— | 24 Oct 2022 |
| Gail Frances McIntyre |
3/4/5
CEO and President, Director
|
—
class O/S missing
|
—
700,000 shares
|
— | 01 Feb 2023 |
| Leonard Scott Dove |
3/4/5
Chief Operating Officer
|
—
class O/S missing
|
—
400,000 shares
|
— | 01 Feb 2023 |
| Maria Carolina Petrini |
3/4/5
Chief Commercial Officer
|
—
class O/S missing
|
—
400,000 shares
|
— | 10 Apr 2023 |
| Robert B. Geller |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
—
400,000 shares
|
— | 01 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to Aravive, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Fredric N. Eshelman
Net 12M change
$0
Latest report
10 Apr 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Fredric N. Eshelman | Executive Chairman, Director, 10%+ Owner | $23,473,906 | Mixed | 24 Oct 2022 | ||
| Eric Zhang | Director | $2,581,796 | Mixed | 24 Oct 2022 | ||
| Amato Giaccia | Director | $1,116,435 | Mixed | 24 Oct 2022 | ||
| Peter Tai-Ching Ho | Director | $101,838 | Mixed | 24 Oct 2022 | ||
| Maria Carolina Petrini | Chief Commercial Officer | Mixed | 10 Apr 2023 | |||
| Sigurd C. Kirk | Director | Mixed | 23 Sep 2022 | |||
| Gail Frances McIntyre | CEO and President, Director | Mixed | 01 Feb 2023 | |||
| Vinay Shah | Chief Financial Officer | Mixed | 24 Jan 2022 | |||
| Leonard Scott Dove | Chief Operating Officer | Mixed | 01 Feb 2023 | |||
| John Hohneker | Director | Mixed | 23 Sep 2022 | |||
| Robert B. Geller | Chief Medical Officer | Mixed | 01 Feb 2023 | |||
| Rudy Howard | Chief Financial Officer | Mixed | 01 Feb 2023 | |||
| Michael W. Rogers | Director | Mixed | 23 Sep 2022 | |||
| Reshma Rangwala | Chief Medical Officer | Mixed | 24 Jan 2022 |
Recent insider transactions for Aravive, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.